Article

Data reveal shift in prostate Ca treatment choices

Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data from the CaPSURE database.

Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
Anna Myers, CNP, answers a question during a Zoom video interview
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Woman at doctor | Image Credit: © rocketclips - stock.adobe.com
Related Content
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
April 25th 2025

FDA clears AI-powered application for measuring prostate volume

Benjamin P. Saylor
Clarius Mobile Health said it will be demonstrating the application at the AUA Annual Meeting in Las Vegas, Nevada.
Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MD
April 24th 2025

Pearls & Perspectives: Premature ejaculation, with Brian L. Steixner, MD

Amy M. Pearlman, MD Brian L. Steixner, MD
Host Amy Pearlman, MD, discusses premature ejaculation with Brian L. Steixner, MD, a board-certified urologist in Linwood, New Jersey.
First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI
April 24th 2025

First patient enrolled in trial of Voro Urologic Scaffold for post-prostatectomy SUI

Hannah Clarke
"What is truly exciting is the potential for this device to meaningfully improve early and long-term continence rates, which can profoundly impact a patient's recovery and overall quality of life,” says Patrick Daily, MD.
Introducing Pearls & Perspectives, with Amy Pearlman, MD!
April 21st 2025

Introducing Pearls & Perspectives, with Amy Pearlman, MD!

Amy M. Pearlman, MD
Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.
Conference Preview: American Urological Association 2025
April 23rd 2025

Conference Preview: American Urological Association 2025

Hannah Clarke
View slated interviews with experts as well as insights from urologists on what to watch for.
Study shows IsoPSA’s predictive ability for clinically significant prostate cancer
April 23rd 2025

Study shows IsoPSA’s predictive ability for clinically significant prostate cancer

Hannah Clarke
"In this large study of over 1500 men with an elevated PSA, we found that a low IsoPSA is incredibly reassuring,” says Christopher J. Weight, MD.
© 2025 MJH Life Sciences

All rights reserved.